Log in

OTCMKTS:MXDHFMDxHealth Stock Price, Forecast & News

0.00 (0.00 %)
(As of 08/7/2020 04:00 PM ET)
Today's Range
Now: $0.74
50-Day Range
MA: $0.86
52-Week Range
Now: $0.74
Average Volume50 shs
Market Capitalization$52.19 million
P/E RatioN/A
Dividend YieldN/A
MDxHealth SA operates as a molecular diagnostics company in Germany, the Netherlands, Poland, the United States, rest of European Union, and internationally. The company develops and commercializes epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. Its tests are based on genetic, epigenetic (methylation) and other molecular technologies, and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The company's product pipeline includes tests for prostate, bladder, kidney, cervical, and brain cancers. Its products include ConfirmMDx, a tissue-based epigenetic test for prostate cancer; SelectMDx, a urine-based mRNA test for prostate cancer; and AssureMDx bladder cancer detection test for patients with unresolved hematuria. The company's preclinical development products comprise InformMDx, a tissue-based gene expression panel for prostate cancer; SelectMDx assay to a point of care testing platform; and MonitorMDx, a blood-based test for prostate cancer. It has collaboration agreement with 3D Signatures Inc. to evaluate prognostic test candidate for prostate cancer. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was founded in 2003 and is headquartered in Herstal, Belgium.
Read More
MDxHealth logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.55 out of 5 stars

Industry, Sector and Symbol

Industry Private households
Previous SymbolNASDAQ:MXDHF



Sales & Book Value

Annual Sales$11.78 million
Book Value$0.33 per share



Market Cap$52.19 million
Next Earnings DateN/A
OptionableNot Optionable
0.00 (0.00 %)
(As of 08/7/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MXDHF News and Ratings via Email

Sign-up to receive the latest news and ratings for MXDHF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

MDxHealth (OTCMKTS:MXDHF) Frequently Asked Questions

How has MDxHealth's stock been impacted by COVID-19 (Coronavirus)?

MDxHealth's stock was trading at $1.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MXDHF stock has decreased by 32.7% and is now trading at $0.74.
View which stocks have been most impacted by Coronavirus

Do Wall Street analysts recommend investors buy shares of MDxHealth?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MDxHealth in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for MDxHealth

Has MDxHealth been receiving favorable news coverage?

News headlines about MXDHF stock have been trending extremely negative this week, according to InfoTrie. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. MDxHealth earned a media sentiment score of -4.8 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future.
View the latest news about MDxHealth

Who are some of MDxHealth's key competitors?

Who are MDxHealth's key executives?

MDxHealth's management team includes the following people:
  • Mr. Michael K. McGarrity, CEO & Director (Age 56)
  • Mr. Kurt Schmidt, Exec. VP of Fin. & Interim CFO (Age 58)
  • Dr. Wim Van Criekinge, Chief Scientific Officer (Age 47)
  • Mr. Joseph Sollee, Chief Compliance Officer, Exec. VP of Corp. Devel. & Gen. Counsel (Age 54)
  • Mr. Jean-Marc Roelandt, CFO & Exec. VP (Leave of Absence) (Age 54)

What is MDxHealth's stock symbol?

MDxHealth trades on the OTCMKTS under the ticker symbol "MXDHF."

How do I buy shares of MDxHealth?

Shares of MXDHF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MDxHealth's stock price today?

One share of MXDHF stock can currently be purchased for approximately $0.74.

How big of a company is MDxHealth?

MDxHealth has a market capitalization of $52.19 million and generates $11.78 million in revenue each year. The company earns $-43,100,000.00 in net income (profit) each year or ($0.53) on an earnings per share basis.

What is MDxHealth's official website?

The official website for MDxHealth is www.mdxhealth.com.

How can I contact MDxHealth?

MDxHealth's mailing address is CAP Business Center Rue d`Abhooz 31, Herstal C9, 4040. The company can be reached via phone at 32042577021 or via email at [email protected]

This page was last updated on 8/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.